Kurzfassung

A 12-Week Multicenter, Randomized, Double-Blind,
Placebo-Controlled Study Comparing the Efficacy and
Safety of LY2439821 to Etanercept and Placebo in
Patients with Moderate to Severe Plaque Psoriasis with a
Long-Term Extension Period